← All companies
ABCL annual net income
AbCellera Biologics Inc.
ABCL - CIK 0001703057
Market cap$1.61 B
Rank#2274
SEC filings297
AbCellera Biologics Inc. net income by year
AbCellera Biologics Inc. (ABCL) reported net income of -$146.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
ABCL net income 2019-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$146.41M | +10.1% |
| FY 2024 | -$162.86M | -11.2% |
| FY 2023 | -$146.40M | -192.4% |
| FY 2022 | $158.52M | +3.3% |
| FY 2021 | $153.46M | +29.1% |
| FY 2020 | $118.92M | +5478.5% |
| FY 2019 | -$2.21M | - |
Net Income of similar companies
Frequently asked questions
How much profit does AbCellera Biologics Inc. make?
AbCellera Biologics Inc. (ABCL) reported net income of -$146.41M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has AbCellera Biologics Inc.'s net income changed over time?
Between fiscal 2019 and fiscal 2025, AbCellera Biologics Inc.'s net income declined from -$2.21M to -$146.41M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.